Thrivent Financial for Lutherans Buys 740 Shares of Maximus, Inc. (NYSE:MMS)

Thrivent Financial for Lutherans increased its stake in shares of Maximus, Inc. (NYSE:MMS) by 0.1% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 794,595 shares of the health services provider’s stock after acquiring an additional 740 shares during the quarter. Thrivent Financial for Lutherans owned about 1.31% of Maximus worth $68,097,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of MMS. Rise Advisors LLC boosted its holdings in shares of Maximus by 1,445.0% during the 1st quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock valued at $26,000 after purchasing an additional 289 shares during the last quarter. GAMMA Investing LLC boosted its stake in Maximus by 224.5% during the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock valued at $29,000 after buying an additional 238 shares during the last quarter. Blue Trust Inc. boosted its stake in Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock valued at $33,000 after buying an additional 262 shares during the last quarter. Kapitalo Investimentos Ltda purchased a new position in Maximus during the 4th quarter valued at approximately $52,000. Finally, Archer Investment Corp increased its stake in Maximus by 8,788.9% in the 2nd quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after acquiring an additional 791 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

Maximus Stock Down 0.6 %

NYSE MMS opened at $89.98 on Friday. The stock has a 50 day moving average price of $89.80 and a 200-day moving average price of $86.14. Maximus, Inc. has a one year low of $72.39 and a one year high of $93.97. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.59 and a current ratio of 1.59. The company has a market capitalization of $5.47 billion, a P/E ratio of 23.62 and a beta of 0.76.

Maximus (NYSE:MMS) last released its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, beating the consensus estimate of $1.47 by $0.27. Maximus had a net margin of 5.59% and a return on equity of 20.91%. The business had revenue of $1.31 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same quarter last year, the business earned $0.78 earnings per share. Maximus’s quarterly revenue was up 10.6% compared to the same quarter last year. As a group, equities analysts predict that Maximus, Inc. will post 6.12 EPS for the current fiscal year.

Maximus Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were paid a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.33%. Maximus’s payout ratio is currently 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.